Requires DOC and county correctional facilities to provide certain inmates with medication-assisted treatment.
Impact
If enacted, A2256 would require the Commissioner of Corrections to implement a treatment program ensuring that all qualified inmates receive appropriate care for substance use disorders. The bill represents a significant shift in how correctional facilities address substance abuse issues, moving towards more integrated healthcare solutions that align with contemporary understanding of addiction and recovery. It also requires the Department of Human Services to collaborate in developing a comprehensive plan for managing both mental health and substance use disorder services, thus enhancing the quality of care available within the prison system.
Summary
Assembly Bill A2256, introduced in the New Jersey legislature, aims to mandate the provision of medication-assisted treatment (MAT) to inmates in state and county correctional facilities who are diagnosed with substance use disorders. The bill emphasizes a comprehensive approach to treatment that incorporates not only medications such as methadone and buprenorphine but also behavioral therapies and counseling to provide holistic support for affected individuals upon their admission into correctional facilities. The legislation defines MAT and outlines the procedures for identifying inmates in need of such treatment during their initial evaluations.
Contention
Despite its potential benefits, A2256 may face criticism regarding its implementation and funding. There are concerns about the adequacy of resources needed to sufficiently support these programs in facilities that may already be overwhelmed. Critics may argue that mandated treatments could face logistical challenges and might not align properly with all inmates' individual needs or their willingness to participate in such programs. The requirement for voluntary agreement and informed consent highlights a crucial aspect of ethical medical practice within the unique environment of a correctional facility.
Imposes requirements on video visitation service contracts for inmates in certain correctional facilities; requires correctional facilities to allow contact visits.
Imposes requirements on video visitation service contracts for inmates in certain correctional facilities; requires correctional facilities to allow contact visits.
Requires DOC to ensure inmates have opportunity to participate in Medicaid pre-enrollment and enrollment sessions at least 60 days prior to release; requires applicable inmates to receive Medicaid card at release.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.